Oxford Biomedica plc announced the appointment of Ms. Catherine Moukheibir to the Board as an Independent Non-Executive Director with effect from December 14, 2021. Ms. Moukheibir has extensive international experience in finance, capital markets and life sciences and is currently serving as a non-executive Board member with various companies Biotalys N.V., Ironwood Pharmaceuticals Inc. and privately-owned CMR Surgical Limited, Asceneuron SA, DNA Script and Noema Pharma. Over the course of her career Ms Moukheibir, has served in senior executive roles and Board positions including at Kymab Limited, Innate Pharma S.A, Ablynx N.V, Genkyotex S.A, MedDay Pharmaceuticals, Zealand Pharma A/S, Zeltia S.A., and Creabilis.